Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000899243-15-006854

Chief Operating Officer sold 496 shares at $5.14 ($2,549)

From the SEC's structured data for this filing

Trades in this filing

Keuer Thomas A · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2015-10-16 Sale : show line 1 in the form −496 $5.14 $2,549 16,938 D
Open-market sales · 496 sh · avg $5.14 · $2,549
Loading xslF345X03/doc4.xml…